Active Recombinant Human LRIG3 Protein, C-6×His tagged

• Cat.No.: LRIG3-08H
• Product Overview: Recombinant Human LRIG3 Protein (Asp28-Thr807) with a C-terminal 6-His tag was expressed in Mouse myeloma cell line.

Specification

• Description: Predicted to act upstream of or within otolith morphogenesis. Located in extracellular space.
• Source: Mouse myeloma cell line
• Species: Human
• Tag: C-6×His
• Bio-activity: Measured by its ability to inhibit proliferation of HeLa human cervical epithelial carcinoma cells. The ED50 for this effect is 1.5-6 μg/mL.
• Molecular Mass: Predicted Molecular Mass: 87.1 kDa
  SDS-PAGE: 105-115 kDa, reducing conditions
• N-terminal Sequence Analysis: Asp28
• Endotoxin: < 1.0/μg of the protein by the LAL method.
• Purity: >95% by SDS-PAGE under reducing conditions and visualized by silver stain.
• Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  12 months from date of receipt, -20 to -70 centigrade as supplied.
  1 month, 2 to 8 centigrade under sterile conditions after reconstitution.
  3 months, -20 to -70 centigrade under sterile conditions after reconstitution.
• Storage Buffer: Lyophilized from a 0.2 μm filtered solution in PBS.
• Reconstitution: Reconstitute at 250 μg/mL in sterile PBS.
• Shipping: The product is shipped with polar packs.

Gene Information

• Gene Name: LRIG3 leucine-rich repeats and immunoglobulin-like domains 3 [ Homo sapiens (human) ]
• Official Symbol: LRIG3
• Synonyms: LRIG3; leucine-rich repeats and immunoglobulin-like domains 3; leucine-rich repeats and immunoglobulin-like domains protein 3; FLJ90440; KIAA3016; LIG-3; LIG3; FLJ26573
• Gene ID: 121227
• mRNA Refseq: NM_001136051
• Protein Refseq: NP_001129523
• MIM: 608870
• UniProt ID: Q6UXM1